Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

VBI Vaccines Inc. (VBIV)

2.46   0.005 (0.2%) 05-22 16:00
Open: 2.5 Pre. Close: 2.455
High: 2.53 Low: 2.3
Volume: 5,071,065 Market Cap: 567M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.531 - 2.544 2.544 - 2.556
Low: 2.273 - 2.285 2.285 - 2.297
Close: 2.44 - 2.46 2.46 - 2.48

Technical analysis

as of: 2020-05-24 6:52:54 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.48     One year: 4.07
Support: Support1: 1.77    Support2: 1.02
Resistance: Resistance1: 2.98    Resistance2: 3.48
Pivot: 1.84
Moving Average: MA(5): 2.41     MA(20): 1.69
MA(100): 1.34     MA(250): 1.03
MACD: MACD(12,26): 0.34     Signal(9): 0.24
Stochastic oscillator: %K(14,3): 72.92     %D(3): 78.37
RSI: RSI(14): 75.81
52-week: High: 2.98  Low: 0.47  Change(%): 21.8
Average Vol(K): 3-Month: 882620  10-Days: 1970948

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
VBIV has closed below upper band by 17.1%. Bollinger Bands are 178.9% wider than normal. The large width of the bands suggest high volatility as compared to VBIV's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.

Headline News

Wed, 06 May 2020
VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Wed, 20 May 2020
Implied Volatility Surging for VBI Vaccines (VBIV) Stock Options - Yahoo Finance

Mon, 11 May 2020
VBI Vaccines' Shares March Higher, Can It Continue? - Yahoo Finance

Mon, 18 May 2020
Market cap of VBI Vaccines Inc. [VBIV] reaches 435.92M – now what? - The DBT News

Fri, 15 May 2020
VBI Vaccines Announces Upcoming Poster Presentation of Phase 1/2a data of VBI-1901 in Recurrent GBM Patients at AACR Virtual Annual Meeting - Business Wire

Tue, 19 May 2020
VBI Vaccines Inc. (NASDAQ:VBIV) Undervalued? Fundamentals Hard To Beat? - State Reviewer

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 231
Shares Float (M) 150
% Held by Insiders 5.26
% Held by Institutions 44.45
Shares Short (K) 8,970
Shares Short P. Month (K) 6,030

Stock Financials

EPS -0.348
EPS Est This Year -0.890
EPS Est Next Year -1.010
Book Value (p.s.) 0.420
Profit Margin
Operating Margin -1832.21
Return on Assets (ttm) -22.3
Return on Equity (ttm) -60.3
Qtrly Rev. Growth 15.3
Gross Profit (p.s.) -0.025
Sales Per Share 0.010
EBITDA (p.s.) -0.174
Qtrly Earnings Growth
Operating Cash Flow (M) -42
Levered Free Cash Flow (M) -30

Stock Valuations

PE Ratio -7.07
PEG Ratio
Price to Book value 5.86
Price to Sales 248.86
Price to Cash Flow -13.40

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2012-12-27
Ex-Dividend Date 2012-02-04
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.